Michal Štefánik

714 total citations
22 papers, 443 citations indexed

About

Michal Štefánik is a scholar working on Public Health, Environmental and Occupational Health, Infectious Diseases and Parasitology. According to data from OpenAlex, Michal Štefánik has authored 22 papers receiving a total of 443 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Public Health, Environmental and Occupational Health, 10 papers in Infectious Diseases and 6 papers in Parasitology. Recurrent topics in Michal Štefánik's work include Mosquito-borne diseases and control (12 papers), Viral Infections and Vectors (6 papers) and Vector-borne infectious diseases (4 papers). Michal Štefánik is often cited by papers focused on Mosquito-borne diseases and control (12 papers), Viral Infections and Vectors (6 papers) and Vector-borne infectious diseases (4 papers). Michal Štefánik collaborates with scholars based in Czechia, Slovakia and United States. Michal Štefánik's co-authors include Daniel Růžek, Luděk Eyer, Jan Haviernik, Martina Fojtíková, Jiřı́ Salát, Zdeněk Hubálek, Ivo Rudolf, Martin Palus, Petra Formanová and Noël Tordo and has published in prestigious journals such as Scientific Reports, Antimicrobial Agents and Chemotherapy and Virology.

In The Last Decade

Michal Štefánik

22 papers receiving 435 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michal Štefánik Czechia 11 219 195 76 61 61 22 443
Jan Haviernik Czechia 11 193 0.9× 149 0.8× 51 0.7× 66 1.1× 68 1.1× 18 360
Erica L. McGrath United States 7 270 1.2× 343 1.8× 120 1.6× 136 2.2× 19 0.3× 11 567
Siti Naqiah Amrun Singapore 15 370 1.7× 300 1.5× 66 0.9× 126 2.1× 20 0.3× 22 642
Igor Andrade Santos Brazil 13 177 0.8× 151 0.8× 57 0.8× 119 2.0× 19 0.3× 41 502
Dilek Turgut‐Balik Türkiye 14 127 0.6× 59 0.3× 28 0.4× 168 2.8× 45 0.7× 35 450
Déborah Garcia France 11 105 0.5× 181 0.9× 104 1.4× 55 0.9× 21 0.3× 20 339
Francis E. G. Cox United Kingdom 5 52 0.2× 243 1.2× 34 0.4× 59 1.0× 77 1.3× 7 393
Sarah C. Atkinson Australia 15 238 1.1× 124 0.6× 56 0.7× 423 6.9× 67 1.1× 26 790
Jennifer L. Güler United States 12 47 0.2× 220 1.1× 95 1.3× 151 2.5× 57 0.9× 26 393
Deepali Savargaonkar India 13 112 0.5× 250 1.3× 35 0.5× 91 1.5× 38 0.6× 31 450

Countries citing papers authored by Michal Štefánik

Since Specialization
Citations

This map shows the geographic impact of Michal Štefánik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michal Štefánik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michal Štefánik more than expected).

Fields of papers citing papers by Michal Štefánik

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michal Štefánik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michal Štefánik. The network helps show where Michal Štefánik may publish in the future.

Co-authorship network of co-authors of Michal Štefánik

This figure shows the co-authorship network connecting the top 25 collaborators of Michal Štefánik. A scholar is included among the top collaborators of Michal Štefánik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michal Štefánik. Michal Štefánik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Štefánik, Michal, Petra Straková, Jan Haviernik, et al.. (2024). Nanoformulation of the Broad-Spectrum Hydrophobic Antiviral Vacuolar ATPase Inhibitor Diphyllin in Human Recombinant H-ferritin. International Journal of Nanomedicine. Volume 19. 3907–3917. 1 indexed citations
2.
Šimečková, Pavlína, Josef Slavík, Andrea Fořtová, et al.. (2024). Tick-borne encephalitis virus modulates sphingolipid and phospholipid metabolism in infected human neuronal cells. Microbes and Infection. 26(4). 105303–105303. 1 indexed citations
3.
Vaculovičová, Markéta, Michal Štefánik, Filip Mravec, et al.. (2024). Light-triggered reactions in a new “light” of nanoparticles engineering. Journal of Photochemistry and Photobiology A Chemistry. 454. 115667–115667. 3 indexed citations
5.
Straková, Petra, Jan Kotouček, Andrea Fořtová, et al.. (2023). Antiviral activity of singlet oxygen-photogenerating perylene compounds against SARS-CoV-2: Interaction with the viral envelope and photodynamic virion inactivation. Virus Research. 334. 199158–199158. 15 indexed citations
6.
Reddy, Paidi Yella, Santhosh Penta, Yogesh S. Sanghvi, et al.. (2023). Efficient synthesis of novel 2-deoxy-C-nucleosides containing oxa and thiadiazole derivatives and their biological activity. Journal of Molecular Structure. 1292. 136099–136099. 5 indexed citations
7.
Štefánik, Michal, Jan Haviernik, Petra Straková, et al.. (2022). Diphyllin Shows a Broad-Spectrum Antiviral Activity against Multiple Medically Important Enveloped RNA and DNA Viruses. Viruses. 14(2). 354–354. 19 indexed citations
8.
Salát, Jiřı́, et al.. (2022). Sero-epidemiology of tick-borne encephalitis in small ruminants in the Czech Republic. Ticks and Tick-borne Diseases. 13(5). 101996–101996. 5 indexed citations
9.
Štefánik, Michal, Petra Straková, Jan Haviernik, et al.. (2021). Antiviral Activity of Vacuolar ATPase Blocker Diphyllin against SARS-CoV-2. Microorganisms. 9(3). 471–471. 22 indexed citations
10.
Salát, Jiřı́, Petra Straková, Michal Štefánik, et al.. (2021). Experimental and Natural Infections of Tick-Borne Encephalitis Virus in Dogs. Viruses. 13(10). 2039–2039. 8 indexed citations
11.
Štefánik, Michal, James J. Valdés, Jan Haviernik, et al.. (2020). FDA-Approved Drugs Efavirenz, Tipranavir, and Dasabuvir Inhibit Replication of Multiple Flaviviruses in Vero Cells. Microorganisms. 8(4). 599–599. 21 indexed citations
12.
Svoboda, Pavel, Michal Štefánik, Jiřı́ Salát, et al.. (2020). An RNA-dependent RNA polymerase inhibitor for tick-borne encephalitis virus. Virology. 546. 13–19. 5 indexed citations
13.
Eyer, Luděk, Pavel Svoboda, Jan Balvan, et al.. (2020). Broad-Spectrum Antiviral Activity of 3′-Deoxy-3′-Fluoroadenosine against Emerging Flaviviruses. Antimicrobial Agents and Chemotherapy. 65(2). 11 indexed citations
14.
Formanová, Petra, Martin Palus, Jiřı́ Salát, et al.. (2019). Changes in cytokine and chemokine profiles in mouse serum and brain, and in human neural cells, upon tick-borne encephalitis virus infection. Journal of Neuroinflammation. 16(1). 205–205. 44 indexed citations
15.
Štefánik, Michal, Petra Formanová, Tomáš Bílý, et al.. (2018). Characterisation of Zika virus infection in primary human astrocytes. BMC Neuroscience. 19(1). 5–5. 54 indexed citations
16.
Haviernik, Jan, Michal Štefánik, Martina Fojtíková, et al.. (2018). Arbidol (Umifenovir): A Broad-Spectrum Antiviral Drug That Inhibits Medically Important Arthropod-Borne Flaviviruses. Viruses. 10(4). 184–184. 100 indexed citations
17.
Eyer, Luděk, Jana Širmarová, Martina Fojtíková, et al.. (2017). Antiviral activity of the adenosine analogue BCX4430 against West Nile virus and tick-borne flaviviruses. Antiviral Research. 142. 63–67. 69 indexed citations
18.
Fernando, Sandun, et al.. (2016). An Approach for Zika Virus Inhibition Using Homology Structure of the Envelope Protein. Molecular Biotechnology. 58(12). 801–806. 23 indexed citations
19.
Štefánik, Michal, et al.. (1995). [Diagnosis of acquired toxoplasmosis using simultaneous determination of specific immunoglobulins M, A and E].. PubMed. 44(3). 107–10. 2 indexed citations
20.
Štefánik, Michal, et al.. (1992). Microbial causative agents of male urethritis.. PubMed. 36(1). 111–8. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026